DETECTION OF THYROGLOBULIN IN FINE NEEDLE ASPIRATES OF NONTHYROIDAL NECK MASSES - A CLUE TO THE DIAGNOSIS OF METASTATIC DIFFERENTIATED THYROID-CANCER

被引:210
作者
PACINI, F
FUGAZZOLA, L
LIPPI, F
CECCARELLI, C
CENTONI, R
MICCOLI, P
ELISEI, R
PINCHERA, A
机构
[1] UNIV PISA, IST ENDOCRINOL, I-56100 PISA, ITALY
[2] UNIV PISA, CATTEDRA ENDOCRINOCHIRURG, I-56100 PISA, ITALY
关键词
D O I
10.1210/jc.74.6.1401
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We studied the feasibility of employing the measurement of thyroglobulin (Tg) in the washout of the needle used to perform the fine needle aspiration cytology (FNA-Tg) for the differential diagnosis of nonthyroidal neck masses of unknown etiology. We studied 35 patients presenting for 1 or more neck lumps outside the thyroid gland. A previous history of treated differentiated thyroid cancer (DTC) was given by 23 patients and of nonthyroidal malignancy by 3 patients. FNA-Tg was measured in the Tg-free serum used to wash out the needle employed for the cytology. Finally, all patients were treated by surgery. FNA-Tg was always detectable in 14 patients with thyroid cancer metastases demonstrated by histology, with a mean (+/-SD) of 27,087 +/- 37,622 ng/FNA (P < 0.002) compared to patients without thyroid cancer metastases (mean +/- SD, 12.1 +/- 4.8 ng/FNA in 7 cases; undetectable in 14 cases). Assuming 21.7 ng/FNA (the mean +/- 2 SD of the negative patients) as the cut-off value, all patients with metastases from DTC were detected by FNA-Tg. FNA-Tg had better negative predictive value than cytology, since this last technique gave 10 inconclusive results, comprising 2 false negative results in patients with metastases from DTC. Our results indicate that elevated concentrations of FNA-Tg in nonthyroidal neck nodes strongly suggest the diagnosis of metastases from DTC.
引用
收藏
页码:1401 / 1404
页数:4
相关论文
共 19 条
[1]   MANAGEMENT OF THYROID-NODULES .2. SCANNING TECHNIQUES, THYROID SUPPRESSIVE THERAPY, AND FINE NEEDLE ASPIRATION [J].
ASHCRAFT, MW ;
VANHERLE, AJ .
HEAD & NECK SURGERY, 1981, 3 (04) :297-322
[2]   SERUM THYROGLOBULIN IN THE MANAGEMENT OF PATIENTS WITH THYROID-CANCER [J].
BARSANO, CP ;
SKOSEY, C ;
DEGROOT, LJ ;
REFETOFF, S .
ARCHIVES OF INTERNAL MEDICINE, 1982, 142 (04) :763-767
[3]   DIAGNOSIS OF PRIMARY THYROID-CARCINOMA BY IMMUNOHISTOLOGICAL DEMONSTRATION OF THYROGLOBULIN [J].
BURT, A ;
GOUDIE, RB .
HISTOPATHOLOGY, 1979, 3 (04) :279-286
[4]   DIAGNOSIS AND TREATMENT OF THYROID, PARATHYROID, AND THYROGLOSSAL DUCT CYSTS [J].
CLARK, OH ;
OKERLUND, MD ;
CAVALIERI, RR ;
GREENSPAN, FS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1979, 48 (06) :983-988
[5]  
DANIEL PM, 1967, IMMUNOLOGY, V12, P489
[6]  
ENZGELL U, 1971, ACTA OTO-LARYNGOL, V72, P138
[7]  
FRANKLIN WA, 1982, CANCER, V50, P939, DOI 10.1002/1097-0142(19820901)50:5<939::AID-CNCR2820500523>3.0.CO
[8]  
2-O
[9]  
HALL TL, 1989, CANCER, V63, P718, DOI 10.1002/1097-0142(19890215)63:4<718::AID-CNCR2820630420>3.0.CO
[10]  
2-N